US Stock MarketDetailed Quotes

KZIA Kazia Therapeutics

Watchlist
  • 0.417
  • +0.056+15.59%
Close Jul 25 16:00 ET
  • 0.413
  • -0.004-1.01%
Post 20:01 ET
12.41MMarket Cap-1141P/E (TTM)

Kazia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kazia Therapeutics Earnings Date

Currency: AUD

Period

H1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.37

+60.54%
Analyst Rating

Buy

Jul 12, 2024

Kazia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/H222.970K / 11.500K--
--2023/H1140.000 / 1.100K--
--2022/H2110.000 / 338.670K--
--2022/H126.950K / 0.000--
--2021/H215.180M / 18.700M--
DatePeriodRevenue/EstimateEarnings Call
--2023/H222.970K / 11.500K--
--2023/H1140.000 / 1.100K--
--2022/H2110.000 / 338.670K--
--2022/H126.950K / 0.000--
--2021/H215.180M / 18.700M--

Unlock Free Earnings Estimates

Kazia Therapeutics Earnings Reports

  • Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 19 16:31 ET

  • Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 27 08:29 ET

  • Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 6, 2023 08:31 ET

  • Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 29, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 12, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg